Brief: Tianjin Development Says Tianjin Pharma May Entrust Members Of Group With Manufacturing, Processing Certain Drugs Under Drug Mah System
19/01/2021 12:28
Jan 19 (Reuters) - Tianjin Development Holdings Ltd
0882.HK :
* TIANJIN PHARMACEUTICAL GROUP MAY ENTRUST MEMBERS OF GROUP
WITH
MANUFACTURING, PROCESSING CERTAIN DRUGS UNDER DRUG MAH SYSTEM
Source text for Eikon: ID:nHKS5YNHKY
Further company coverage: 0882.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln